Apomorphine antagonism of the elevation of homovanillic acid induced by antipsychotic drugs.
D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D002746:Chlorpromazine / Q000037:antagonists & inhibitors; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D006220:Haloperidol / Q000037:antagonists & inhibitors; D006719:Homovanillic Acid / Q000378:metabolism; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D010648:Phenylacetates / Q000378:metabolism*; D011941:Receptors, Adrenergic / Q000187:drug effects; D013329:Structure-Activity Relationship; D009435:Synaptic Transmission / Q000187:drug effects; D013888:Thiothixene / Q000037:antagonists & inhibitors; D014149:Tranquilizing Agents / Q000037:antagonists & inhibitors*; D014268:Trifluoperazine / Q000037:antagonists & inhibitors
D010648:Phenylacetates; D011941:Receptors, Adrenergic; D014149:Tranquilizing Agents; D014268:Trifluoperazine; D013888:Thiothixene; D009020:Morphine; D000547:Amantadine; D006220:Haloperidol; D001058:Apomorphine; D002746:Chlorpromazine; D004298:Dopamine; D006719:Homovanillic Acid